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Abstract: The pharmacokinetics of gentamicin, tobramycin, amikacin, kanamycin, and apramycin were investigated
after single intravenous administration in goats. Their antimicrobial activity against 30 strains of Staphylococcus aureus
isolates from goats was also studied. On the base of the pharmacokinetic and pharmacodynamic data, a comparison
between antibiotics was made.
All 5 antibiotics showed a marked high in vitro antibacterial activity. The lowest MIC90 values were those of amikacin and
the highest one was of kanamycin. The ratios of Cmax/MIC showed that amikacin has an advantage of providing the
highest values of the concentration/MIC90 ratio, as well of the time providing bactericidal levels, followed by apramycin,
whereas the other 3 antibiotics had comparable values, but lower than the first 2 antibiotics. The same interpretation
could be made for the area under the curve/MIC90 ratio.
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Introduction
Aminoglycoside antibiotics are widely used in
veterinary medicine, primarily for the treatment and
prevention of gram-negative infections. The most
common investigations in this area are on their
pharmacodynamics and, particularly on their
antimicrobial activity (1-4). The studies on their
pharmacokinetics are also conformed to their activity
against gram-negative agents (5-8). It is well known,
however, that aminoglycosides exhibit an antibacterial
activity against gram-positive microorganisms and

are used for treatment of diseases caused by these
organisms (9). Data based on the integration of
pharmacokinetic parameters in different species and
data for the antimicrobial activity of aminoglycosides
against gram-negative microorganisms were reported
(4,10-12), but with regard to gram-positive bacteria,
they are limited or lacking. The number of
publications presenting comparative pharmacokinetic
and pharmacodynamic data for the members of this
group is also scarce (3,13,14). There are no previous
reports on comparative pharmacokinetics and
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pharmacodynamics of aminoglycoside antibiotics in
goats. Therefore, the present study aimed to compare
several basic pharmacokinetic parameters of 5
aminoglycosides and aminocyclitols (gentamicin,
tobramycin, amikacin, apramycin, and kanamycin) in
goats and the pharmacodynamic indices showing
their activity against staphylococcal isolates from
caprine.

Experimental procedure
Antibiotics were injected once intravenously as a
single bolus in v. jugularis. Blood samples from all
treated animals were withdrawn prior to and at 0.083,
0.25, 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 24 h post treatment
from the contralateral vein. They were kept at room
temperature for 2 h and the separated serum stored
for 48 h at -20 °C until the microbiological assay (15).
In Table 2 are presented the characteristics of the
method for the antibiotics used.

Material and Methods

Pharmacokinetic analysis

Animals

Pharmacokinetic parameters, based on the serum
concentrations, were calculated with the
WINNONLIN 4.0.1. (Pharsight Corporation, 800
West El Camino Real, Mountain View, CA, USA)
software using the compartmental approach. The
choice of a model of best fit to blood concentration
curves was performed according to Akaike’s
criterion.

Experiments with each antibiotic were performed
on a group of 6 adult (2-4 years) non-lactating, nonpregnant goats. During the time of the experiments,
the animals weighed between 38.62 ± 3.51 and 45.9 ±
3.51 kg. They were fed standard grass and concentrate
mixtures according to the requirements of the species
and fasted 12 h prior to the respective experiment
beginning. Drinking water was provided ad libitum.

Statistical analysis

Drugs

The values of pharmacokinetic parameters are
presented as mean ± standard deviation (mean ± SD).

The medications used and their doses are
presented in Table 1.

Table 1. Antibiotics used in the investigation.
Antibiotic

Drug form (company, city, country)

Drug
concentration

Dose
(mg/kg)

Amikacin
Tobramycin

Ampoules amikacin sulphate 2 ml (Sopharma, Sofia, Bulgaria)

25%

10

Substance tobramycin 983 μg/ml (Actavis, Sofia, Bulgaria)

10%

5

Apramycin

Phials apramycin sulfate 50 ml (Actavis, Sofia, Bulgaria)

20%

20

Gentamicin

Phials gentamicin sulfate 50 ml (Actavis, Sofia, Bulgaria)

10%

4

Kanamycin

Phials kanamycin sulfate 100 ml (Alfasan, Worden, Holland)

25%

10

Table 2. Characteristics of the antibiotic determination methods using Bacillus subtilis
ATCC 6633.
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Antibiotic

LOQ (mg/ml)

r2

Intra-assay
CV (%)

Inter-assay
CV (%)

Amikacin

0.08

0.9892

7.12

14.38

Tobramycin

0.02

0.9949

5.23

8.62

Gentamicin

0.02

0.9802

3.43

9.76

Kanamycin

0.16

0.9858

5.14

6.37

Apramycin

0.04

0.995

7.34

11.42
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Microbiological studies
The study was performed with a total of 30 strains
belonging to Staphylococcus spp. Out of them, 19 were
identified as Staphylococcus aureus and 11 as
coagulase-negative
species,
identified
as
Staphylococcus epidermidis (7 strains), Staphylococcus
caprae (2 strains), and Staphylococcus xylosus (2
strains). They were isolated from goats suffering from
various local infections.
The isolates were identified by Gram staining;
haemolytic activity, tests of catalase, oxidase and
motility, fermentation of mannitol, production of
DNA-ase and plasmocoagulase as well as additional
identification were carried out by the semi-automated
system CRYSTAL (Becton Dickinson).
For MIC determination, the macrobroth dilution
test was performed in tubes with a final volume of 1
ml according to “Methods for Dilution Antimicrobial
Susceptibility Test for Bacteria That Grow
Aerobically”. Approved Standard M7-A3. Clinical and
Laboratory Standard Institute, Villanova, Pa. 1999
(16).
For quality control of the method, reference strains
providing MIC values to all tested antimicrobials
according to CLSI requirements were selected. In
concordance to the CLSI method, MIC was
interpreted using Staphylococcus aureus ATCC 25922
as reference strain. The theoretical curves, showing

the relationship between the number of sensitive
strains and antibiotic concentrations, were used to
obtain MIC90.
On the basis of selected pharmacokinetic
parameters and MIC90 values of the 5 antibiotics,
several PK/PD parameters were calculated.
Results
Pharmacokinetics
The blood serum concentration versus time curves
of the 5 antibiotics (Table 3) fitted biexponential
functions:
Gentamicin: Ct
11.42.exp(-0.4349.t);

=

24.19.exp(-4.1731.t)

+

Amikacin: Ct = 77.23.exp(-4.3614.t) + 23.37.exp(0.337.t);
Tobramycin: Ct = 29.67.exp(-9.714.t) + 8.66.exp(0.4029.t);
Kanamycin: Ct
20.01.exp(-0.3376.t);

=

51.15.exp(-6.3768.t)

+

Apramycin: Ct
53.47.exp(-0.528.t).

=

174.66.exp(-7.6728.t)

+

Selected pharmacokinetic parameters, calculated
based on a 2-compartment model, are presented in
Table 4.

Table 3. Serum concentrations of gentamicin, tobramycin, amikacin, kanamycin, and apramycin after single
i.v. administration in goats (mean ± SD).
Time (h)

Gentamicin
(4 mg/kg)

Amikacin
(10 mg/kg)

Тоbramycin
(5 mg/kg)

Каnamycin
(10 mg/kg)

Apramycin
(20 mg/kg)

0.083
0.25
0.5
1
2
3
4
6
8
10
12
24

28.0 ± 4.46
20.05 ± 3.8
12.55 ± 1.3
7.88 ± 1.27
5.77 ± 1.15
1.94 ± 0.33
1.57 ± 0.25
1.28 ± 0.29
0.84 ± 0.46
0.44 ± 0.24
0.23 ± 0.13
0.02 ± 0.01

76.77 ± 9.79
51.27 ± 6.88
37.59 ± 5.64
17.96 ± 3.63
11.02 ± 3.56
10.55 ± 3.60
6.84 ± 1.64
3.69 ± 1.94
1.63 ± 0.69
0.74 ± 0.3
0.47 ± 0.15

21.44 ± 8.41
13.96 ± 6.74
10.18 ± 3.77
6.75 ± 1.96
3.51 ± 0.42
2.54 ± 0.53
1.79 ± 0.23
0.88 ± 0.15
0.52 ± 0.12
0.34 ± 0.08
0.22 ± 0.06

47.38 ± 3.65
25.43 ± 4.84
22.66 ± 5.77
14.84 ± 3.3
10.69 ± 1.21
9.15 ± 2.05
4.38 ± 0.53
2.35 ± 0.38
1.28 ± 0.26
0.48 ± 0.12
0.28 ± 0.11

140.29 ± 25.03
70.62 ± 8.4
45.86 ± 8.83
31.28 ± 5.26
17.36 ± 2.64
12.99 ± 2.4
5.77 ± 2.6
2.12 ± 1.73
0.5 ± 0.31
0.21 ± 0.24
0.05 ± 0
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Table 4. Pharmacokinetic parameters of aminoglycosides in goats (mean ±SD).
Antibiotics
Parameters

Dose
AUC
AUC/D
t1/2a
t1/2b
C0
ClB
AUMC
MRT
Vss
K12
K21
Vd(area)
β.100/К10

Units

mg/kg
h.μg/ml
h
h
μg/ml
ml/min/kg
h2.μg/ml
h
l/kg
h-1
h-1
l/kg
%

Gentamicin

Amikacin

Tobramycin

Kanamycin

Apramycin

4
33.09 ± 5.13
8.27 ± 1.28
0.19 ± 0.07
1.81 ± 0.85
35.6 ± 7.2
2.06 ± 0.347
71.51 ± 36.39
2.1 ± 0.81
0.252 ± 0.073
1.614 ± 1.267
1.584 ± 1.108
0.312 ± 0.114
40.45 ± 12.2

10
95.13 ± 20.58
9.51 ± 2.06
0.23 ± 0.12
2.42 ± 0.8
100.6 ± 23.4
1.816 ± 0.36
259.80 ± 128.47
2.6 ± 0.81
0.270 ± 0.054
2.138 ± 1.643
1.4293 ± 1.24
0.366 ± 0.11
29.93 ± 7.9

5
26.75 ± 5.65
5.351 ± 1.13
0.17 ± 0.13
1.82 ± 0.5
38.3 ± 18.3
3.23 ± 0.67
57.23 ± 15.3
2.17 ± 0.5
0.428 ± 0.16
6.448 ± 8.39
2.190 ± 1.29
0.508 ± 0.16
32.42 ± 13.3

10
69.61 ± 8.6
6.96 ± 0.86
0.18 ± 0.1218
2.06 ± 0.5884
71.2 ± 24.8
2.42 ± 0.31
180.99 ± 46.0
2.59 ± 0.88
0.375 ± 0.177
3.844 ± 3.327
1.821 ± 0.78
0.431 ± 0.186
36.44 ± 14.39

20
123.4 ± 18.04
6.17 ± 0.9
0.1±0.04
1.32 ± 0.09
228.1 ± 65.9
2.759 ± 0.479
195.15 ± 35.1
1.58 ± 0.08
0.26 ± 0.038
4.124 ± 1.432
2.215 ± 0.487
0.315 ± 0.059
30.86 ± 11.17

D – dose;
t1/2 - distribution half-life;
t1/2 - elimination half-life;
AUC - area under the concentration-time curves;
Vdarea, - volume of distribution;

Vss - steady-state volume of distribution;
MRT - mean residence time;
ClB - total body clearance;
AUMC - area under the first moment curve;
MRT – mean residence time

Minimum inhibitory concentrations
The observed MIC values for gentamicin are
within the range of 0.2 - 0.5 μg/ml. There was no
intermediate or resistant isolate. MIC90 was 0.5 μg/ml
(Figure).
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Figure. Curves of the antibacterial activity of tobramycin,
amikacin, apramycin, gentamicin, and kanamycin,
presented through MIC, against caprine Staphylococcus
spp. isolates.

Amikacin. MIC values ranged between 0.1 and 0.2
μg/ml. MIC90 was 0.1 μg/ml, the lowest inhibitory
concentration determined for all tested antibiotics.
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All 30 tested Staphylococcus spp. strains showed a
marked sensitivity to tobramycin. The determined
inhibitory concentrations were from 0.1 tо 0.5 μg/ml,
MIC90 was 0.5 μg/ml.
For kanamycin, the MIC range was between 0.1
and 1.0 μg/ml. MIC90 was 1 μg/ml; or kanamycin
showed the lowest activity, compared to the tested
aminoglycosides and apramycin.
MIC values for apramycin ranged between 0.1 and
0.5 μg/ml, i.e. all 30 tested isolates showed a marked
sensitivity. MIC90 was 0.5 μg/ml - equal to those of
tobramycin and gentamicin.
The values of PK/PD calculations of the 5
antibiotics are presented in Table 5.
Discussion
In the present paper the pharmacokinetic data
were calculated on the base of recommended and
used doses. The serum antibiotic levels and the
respective pharmacokinetic parameters allowed a

Т. DINEV, V. URUMOVA, М. LYUTSKANOV, L. LASHEV

Table 5. Ratios of some pharmacokinetic parameters of aminoglycosides in goats to MIC90 against
staphylococci (mean ± SE).
Parameters
Antibiotic

Gentamicin
Amikacin
Tobramycin
Kanamycin
Apramycin

C°/MIC90

C(5 min)/MIC90

T (C10) > MIC90 (h)

AUC/MIC90

71.22 ± 5.89
998.43 ± 97.93
76.65 ± 14.98
71.16 ± 10.33
456.27 ± 53.84

56 ± 3.64
767.68 ± 39.97
42.87 ± 6.87
47.38 ± 1.63
280.57 ± 20.44

2.08 ± 0.11
9.22 ± 0.42
1.38 ± 0.13
2.44 ± 0.38
4.4 ± 0.39

73.07 ± 4.31
969.67 ± 66.4
56.1 ± 5.3
68.86 ± 3.45
250.98 ± 15.96

C°/MIC90 – ratio of C° to MIC90;
C(5 min)/MIC90 – ratio of the concentration by post injection min 5 to MIC90;
T (C10) > MIC90 – time that plasma concentration remains higher than 10 times the MIC90;
AUC/MIC90 – ratio of area under the curve (AUC) to MIC90.
T(C10) – time that plasma concentrations remain higher than 10 times the MIC90

general evaluation that they present the typical
pharmacokinetics of aminoglycosides – a short
distribution phase and low volume of distribution, as
well as persistence within detectable concentration
range in at least 12 h. In the available literature, there
is a varying number of data about gentamicin,
amikacin,
apramycin,
and
kanamycin
pharmacokinetics in goats (17-22). Our data
confirmed at a considerable extent the results of other
authors. At the same time, however, the significant
variations in the data of various investigators about
the different antibiotics should also be taken into
consideration (23,24).

also
a
well-defined
difference
in
the
intercompartmental transfer of examined antibiotics.
The most intensive transfer was that of tobramycin,
followed by apramycin, and the least intensive one was
that of gentamicin. A more intensive transfer of
tobramycin compared to gentamicin was established
also in guinea pigs (14).

Despite the observed similar values describing the
pharmacokinetics of the 5 examined antibiotics, in the
present paper some variations could also be
distinguished. The distribution of apramycin was the
fastest whereas that of amikacin was the slowest.
According to the distribution volumes data, the
antibiotics were arranged in descending order as
followed: tobramycin, kanamycin, amikacin,
apramycin, and gentamicin. According to the
percentage of antibiotic in the central compartment
after the finished distribution, the order was:
amikacin, apramycin, tobramycin, kanamycin, and
gentamicin. Although the differences in the volumes
of distribution may have species-related specificity in
guinea pigs, the distributions of gentamicin and
tobramycin are reported to be the same (13). There is

All 5 antibiotics showed a marked high in vitro
antibacterial activity. Concentration-depending
killing is a characteristic of aminoglycosides. The
major pharmacodynamic parameters that correlate
with clinical and bacteriologic efficacy of these drugs
are 24-h area under serum drug concentration curve
(AUC) to MIC ratio (≥25-30), or the peak drug
concentration to MIC ratio (≥10-12) based on
unbound serum concentration values (25). The
bound part of the serum levels of aminoglycosides are
very low and can be ignored.

The elimination rate of antibiotics also exhibited
differences. The fastest elimination rate was that of
apramycin, followed by gentamicin, tobramycin,
kanamycin, and amikacin. With regard to their
bactericidal concentration-depending effect, the time
of persistence was not of primary significance.

The ratios between the investigated parameters to
MIC90 showed that amikacin has an advantage of
providing
the
highest
values
of
the
concentration/MIC90 ratio as well of the time of
227
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providing bactericidal or inhibitory levels, followed
by apramycin, whereas the other 3 antibiotics had
comparable values, but lower than the first 2
antibiotics. The same interpretation could be made
for the area under the curve/MIC90 ratio.

Our data allow us to expect some advantages of
amikacin followed by apramycin as active antibiotics
against Staphylococcus aureus strains compared to
other aminoglycosides (tobramycin, gentamicin, and
kanamycin).
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